Project extension approved

The European Commission has approved a 6-month extension of the ONCORELIEF project. The project will continue until June 2023, which will give more time to the pilot site execution, ensuring collection of larger on-site data. This will provide enough information to power the developed AI methods for patient monitoring and Quality of Life prediction, as well as conduct a more comprehensive assessment of the ONCORELIEF solution as a whole.